[A possible adverse effect from the association of losartan-mefenamic acid in hemodialysis].
Khazine
F
F
Simons
O
O
D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001262:Atenolol / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D005922:Glomerulonephritis, IGA / Q000150:complications / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D019808:Losartan / Q000009:adverse effects* / Q000627:therapeutic use; D008528:Mefenamic Acid / Q000009:adverse effects* / Q000627:therapeutic use; D006435:Renal Dialysis
D000959:Antihypertensive Agents; D016861:Cyclooxygenase Inhibitors; D008528:Mefenamic Acid; D001262:Atenolol; D005665:Furosemide; D019808:Losartan